Research Overview
IGF-LR3 (Long R3 Insulin-Like Growth Factor-1) is a recombinant analogue of insulin-like growth factor-1 studied in research models involving IGF-1 receptor signaling, cellular proliferation, tissue regeneration, skeletal muscle physiology, and growth factor biology.
Engineered with an extended amino acid sequence and reduced affinity for insulin-like growth factor binding proteins (IGFBPs), IGF-LR3 has become an important research tool for investigating sustained IGF-1 receptor activation, cellular signaling, and the molecular pathways that regulate growth, differentiation, and tissue maintenance.
Lyophilized Vial Format
Precision-manufactured and lyophilized for stability, this research-grade peptide is produced to support reproducible laboratory workflows requiring accurate preparation, controlled storage, and consistent experimental performance.
Why Researchers Study IGF-LR3
IGF-LR3 is investigated for its interaction with the insulin-like growth factor-1 receptor (IGF-1R), a signaling pathway that plays a fundamental role in cellular growth, protein synthesis, and tissue physiology. Its structural modifications reduce binding to IGF-binding proteins, allowing researchers to examine prolonged receptor signaling and downstream cellular responses in experimental models.
Its well-characterized biological profile has established IGF-LR3 as a valuable research peptide for studying growth factor biology, regenerative processes, skeletal muscle physiology, and the complex molecular networks that coordinate cellular adaptation and tissue remodeling.
Research Applications
Researchers commonly utilize IGF-LR3 in laboratory investigations involving:
- IGF-1 receptor signaling
- Growth factor biology
- Cellular proliferation
- Cellular differentiation
- Tissue regeneration
- Skeletal muscle physiology
- Protein synthesis research
- IGF-binding protein biology
- Cellular signaling
- Experimental developmental biology
